Sector
PharmaceuticalsOpen
₹63.62Prev. Close
₹65.25Turnover(Lac.)
₹2.19Day's High
₹66.89Day's Low
₹62.252 Week's High
₹87.4652 Week's Low
₹31.9Book Value
₹19.4Face Value
₹10Mkt Cap (₹ Cr.)
225.71P/E
0EPS
0Divi. Yield
07 Feb 2025
12:00 AM
Board Meeting
Agenda : Audited Result
6 Jan 2024
12:00 AM
EGM
28 Aug 2024
12:00 AM
AGM
Announcement Date: 28 Aug, 2024
30 Aug 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 35.27 | 21.44 | 10.27 | 10.27 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 35.79 | 0.98 | -1.6 | -1.74 |
Net Worth | 71.06 | 22.42 | 8.67 | 8.53 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 3.93 | 8.55 | 0 | 0.44 |
yoy growth (%) | -53.93 | 0 | -100 | -62.64 |
Raw materials | -3.57 | -8.15 | 0 | -0.49 |
As % of sales | 90.66 | 95.41 | 0 | 110.08 |
Employee costs | -0.04 | -0.04 | -0.02 | -0.06 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 0.14 | 0.08 | -0.37 | -0.36 |
Depreciation | 0 | -0.04 | -0.03 | 0 |
Tax paid | 0 | 0 | 0.4 | -0.01 |
Working capital | -0.05 | -0.09 | -0.16 | -0.62 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -53.93 | 0 | -100 | -62.64 |
Op profit growth | 28.21 | -131.86 | -13.1 | 12.42 |
EBIT growth | 61.7 | -123.62 | 1.95 | -7.53 |
Net profit growth | 55.54 | 178.26 | -108.69 | -451.66 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 |
|---|---|---|
Gross Sales | 15.11 | 0 |
Excise Duty | 0 | 0 |
Net Sales | 15.11 | 0 |
Other Operating Income | 0 | 0 |
Other Income | 0.88 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Venu Madhava Kaparthy
Executive Director
Mini Manikantan
Independent Non Exe. Director
P N Vijay
Independent Non Exe. Director
Methuku Nagesh
Non Executive Director
Shreedhara Shetty
Chairman (Non-Executive)
Shankarappa Nagaraja Vinaya Babu
Independent Non Exe. Director
M Sudheer Anand
Company Sec. & Compli. Officer
Prasanna Subramanya Bhat.
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Pharmaids Pharmaceuticals Ltd
Summary
Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc. The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards. The Company is primarily engaged in business of manufacturing of Generics, Bulk Drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation. Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019. Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019. The Company acquired 25.5% stake as 1st tranche in Anugraha Chemicals, a Partnership Firm, registered under Karnataka Partnership Rules, 1954 on February 1, 2023.
Read More
What is the Pharmaids Pharmaceuticals Ltd share price today?
The Pharmaids Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹64 today.
What is the Market Cap of Pharmaids Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pharmaids Pharmaceuticals Ltd is ₹225.71 Cr. as of 09 May ‘25
What is the PE and PB ratio of Pharmaids Pharmaceuticals Ltd?
The PE and PB ratios of Pharmaids Pharmaceuticals Ltd is 0 and 3.36 as of 09 May ‘25
What is the 52 Week High and Low of Pharmaids Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a Pharmaids Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Pharmaids Pharmaceuticals Ltd is ₹31.9 and ₹87.46 as of 09 May ‘25
What is the CAGR of Pharmaids Pharmaceuticals Ltd?
Pharmaids Pharmaceuticals Ltd's CAGR for 5 Years at 67.70%, 3 Years at 75.36%, 1 Year at 22.35%, 6 Month at -13.66%, 3 Month at -9.14% and 1 Month at -1.27%.
What is the shareholding pattern of Pharmaids Pharmaceuticals Ltd?
The shareholding pattern of Pharmaids Pharmaceuticals Ltd is as follows:
Promoters - 5.22 %
Institutions - 0.00 %
Public - 94.78 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
